Generics
DifGen Pharmaceuticals completes European Decentralised Procedure for Tafamidis 61 mg Capsules
28 October 2026 - US-based pharmaceutical company DifGen Pharmaceuticals LLC announced on Tuesday the successful completion of the European Decentralised Procedure (DCP) for Tafamidis 61 mg Capsules, ...
Orion Pharma to commercialise pembrolizumab biosimilar in Europe
6 October 2026 - Finnish pharmaceutical company Orion Corporation (Orion Pharma) (HEL:ORNBV) announced on Tuesday an agreement with Qilu Pharma Europe to commercialise Qilu's intravenous (IV) pem...
Zydus and MSN announce US launch of generic Adempas (Riociguat Tablets)
6 October 2026 - India-based pharmaceutical companies Zydus Lifesciences Limited and MSN Laboratories Private Limited announced on Monday the launch of Riociguat Tablets, 0.5 mg, 1 mg, 1.5 mg, 2 mg an...
Renova Pharmaceuticals launches first three US generic products
11 September 2026 - Generic medicines developer Renova Pharmaceuticals LLC announced on Thursday the commercial launch of its first three FDA-approved generic products in the United States: L-Glutamin...
Prasco increases Ohio pharmaceutical footprint
1 September 2026 - Prasco LLC, a pharmaceutical commercialisation company specialising in authorised generics, today announced on Monday the acquisition of a strategically located distribution facilit...
Upsher-Smith launches Glatiramer Acetate Injection generic
21 August 2026 - Upsher-Smith Laboratories LLC, a US subsidiary of Bora Pharmaceuticals Co Ltd (TW:6472) (OTCQX:BORAY), announced on Thursday the launch of Glatiramer Acetate Injection in 20 mg/mL and...